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Glycation, oxidation, and nitration of endogenous proteins
occur spontaneously and these modifications are also
present in foods. Increased levels of these chemical changes
are associated with chronic renal failure; however, little is
known about acute kidney failure. We measured these
modifications of plasma protein and related free adducts in
plasma following bilateral nephrectomy and bilateral ureteral
obstruction. Advanced glycation end-product (AGE) residues
of plasma protein were increased 3 h post-surgery, and
thereafter slowly decreased in all groups, reflecting changes
in plasma protein synthesis and transcapillary flow
post-surgery. Ureteral ligation increased oxidation and
nitration adduct residues. There were, however, marked
increases in AGE, dityrosine, or 3-nitrotyrosine free adducts in
both nephrectomized and ureter-ligated rats compared to
rats that had undergone sham operations. There were lower
modified adduct concentrations in the ureter-ligated
compared to the nephrectomized rats, reflecting residual
glomerular filtration and tubular removal. There was no
increase in glycated, oxidized, and nitrated proteins. Glyoxal
and methylglyoxal were also increased in both renal failure
models. Our study shows that the acute loss of renal function
and urinary excretion leads to the accumulation of AGE,
oxidation, and nitration free adducts in the plasma.
Kidney International (2007) 72, 1113–1121; doi:10.1038/sj.ki.5002513;
published online 29 August 2007
KEYWORDS: acute renal failure; nephrectomy; obstructive nephropathy;
advanced glycation end products; oxidative stress
Clinical uremia is associated with a marked accumulation in
plasma of dicarbonyl glycating agents and proteolysis
products of glycated proteins.1–4 Increased protein glycation,
oxidation, and nitration are associated with loss of renal
function.5–7 It is currently unclear whether the marked
increases in proteolysis products of glycated proteins in
plasma found in chronic renal failure are also characteristic of
acute loss of renal function. In addressing this question, we
studied two models of renal failure: the bilateral nephrecto-
mized (BNX) rat model of acute loss of renal function8 and
the bilateral ureteral ligated (BUL) rat model9—models of
acute total loss and partial loss of renal function, respectively.
In the BNX model, there is an acute absence of all kidney
function. This is not a common clinical condition—limited
to rare cases of nephrectomy of tumor-bearing kidneys. In
the BUL model, there is obstructive uropathy, which is a
more frequent cause of acute renal failure (ARF) and found
in approximately 10–15% of the ARF patients. There is a
total loss of urinary excretion with markedly decreased renal
clearance. In the rat, glomerular filtration rate (GFR) is
approximately 30% of normal in the first 24 h—associated
with a tubular reabsorptive capacity for sodium and water,
and metabolic effects (including gluconeogenesis).10–12 There
is a high renal endocrine activity, with stimulation of the
renin–angiotensin system, and increased formation of
thromboxane A2, endothelin, vasopressin, prostaglandins,
and erythropoietin.13
In both models of ARF, the development of uremia—as
judged by the increased plasma urea and creatinine
concentrations—is very similar. However, in the BUL rat
model, the partial persisting renal clearance could be
important in the removal of glycation, oxidation, and
nitration free adducts. As evaluated by the plasma concen-
tration of urea and creatinine, both models represent a
comparable severity of renal failure, whereby the BUL rats
still exhibit minor clearance function, as indicated in our
study by lower levels of b2-microglobulin. The BNX and BUL
models allow us to assess the effect of total loss of clearance
(BNX) and residual clearance (BUL) on the plasma
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concentrations of glycation, oxidation, and nitration free
adducts. They are without the confounding effects observed
in clinical ARF such as cardiovascular complications, multi-
organ failure, and infections.
Glycation of proteins is a complex series of parallel and
sequential reactions collectively called the Maillard reaction.
It occurs in all tissues and body fluids. Early stage reactions
with glucose lead to the formation of Ne-fructosyl-lysine
(FL), and later stage reactions form advanced glycation end
products (AGEs). Glyoxal, methylglyoxal (MG), and 3-
deoxyglucosone (3-DG) are also AGE precursors formed
mainly by lipid peroxidation, degradation of triosepho-
sphates, and glycated proteins, respectively. Quantitatively
important AGEs are hydroimidazolones derived from
arginine residues modified by glyoxal, MG, and 3-DG,
G-H1, MG-H1, and 3DG-H, respectively. Other important
and widely studied AGEs are Ne-carboxymethyl-lysine
(CML), Ne-carboxyethyl-lysine (CEL), and protein crosslinks,
MG-derived lysine dimer (MOLD), and the lysine–arginine-
derived fluorescent crosslink pentosidine.14 The rate of
glycation reactions is often enhanced in uremia by increased
concentrations of a-oxoaldehydes, particularly of glyoxal,
MG, and 3-DG.2,3 Proteins also suffer oxidative damage,
forming methionine sulfoxide (MetSO) residues15 and
dityrosine residues; the latter adduct may be formed both
nonenzymatically16 and enzymatically.17 Protein nitrosative
damage forms 3-nitrotyrosine (3-NT) residues.18 Glycation,
oxidation, and nitration adduct residues are formed by
spontaneous damage of endogenous cellular and extracellular
proteins, and are also present in ingested food.19 Glycation,
oxidation, and nitration free adducts are found in plasma,
urine, and other physiological fluids and originate from the
turnover of endogenous damaged proteins by cellular
proteolysis as well as digestion of food.20,21 Glycation,
oxidation, and nitration free adducts—glycated, oxidized,
and nitrated amino acids—are the major form in which
glycation, oxidation, and nitration damage to proteins is
cleared from the body20 (Figure 1).
Herein, we report the effect of BNX, BUL, and sham
operation on the concentrations of a-oxoaldehyde glycating
agents and markers of protein glycation, oxidation, and
nitration in plasma.
RESULTS
Body weight and parameters of renal function
When the BNX and BUL rats were killed, their mean body
weight was not significantly different from the sham-
operated controls. The plasma urea concentration increased
in the sham-operated controls 3 h after the surgery and
thereafter decreased and remained at 4.6–5.3 mM from 12 to
72 h. In the BNX and BUL rats, plasma urea concentration
increased progressively from 3 to 72 h. At 72 h, the plasma
urea concentration was increased 18-fold in the BNX rats and
20-fold in the BUL rats, with respect to sham-operated
controls. Similarly, the concentration of creatinine in plasma
increased rapidly and progressively in the BNX and BUL rats,
with respect to the sham-operated controls. At 72 h, the
plasma creatinine concentration was increased 20-fold in the
BNX rats and 19-fold in the BUL rats.
The plasma concentration of b2-microglobulin did not
change significantly in the sham-operated controls during
the 72 h post-surgery period. In the BNX rats, plasma
b2-microglobulin concentration increased 5- to 6-fold
relative to the sham-operated controls in the 12–24 h post-
surgery period. In the BUL rats, the plasma b2-microglobulin
concentration did not change significantly over the 24 h
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Figure 1 | Biodistribution scheme illustrating flows of formation and removal (degradation and excretion) of protein glycation,
oxidation, and nitration free adducts in tissues, blood, and urine.
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post-surgery but was increased twofold after 72 h, relative to
the sham-operated controls. The plasma concentration of
b2-microglobulin in the BUL rats was significantly lower than
in the BNX rats at 12 h and 24 h post-surgery, indicating
a residual glomerular filtration (Table 1).
Plasma potassium concentration in the BNX and BUL rats
declined at 12 h post-surgery and then increased at 24 and
72 h post-surgery to final concentrations 2- to 3-fold higher
than in the sham-operated controls. The plasma albumin
concentration was maintained in the sham-operated controls
(except for a temporary decline at 24 h). In the BNX rats,
plasma albumin concentrations declined progressively to a
minimum of 58% of the initial value at 72 h. In the BUL rats,
however, plasma albumin concentration was maintained
until 24 h post-surgery and then increased 32% by 72 h.
Markers of oxidative stress and oxidative damage in plasma
A plasma marker highly sensitive to oxidative stress is plasma
thiols—reflecting mostly cysteine-34 of serum albumin.22 In
the sham-operated control, BNX, and BUL rats, plasma thiol
concentration decreased to a minimum at 12 h post-surgery:
approximately 50% of the baseline concentration in sham-
operated controls, and 60% in the BNX and BUL rats. The
plasma thiol concentration recovered in all groups after 24 h
but remained 21–34% decreased at 72 h, with respect to
baseline controls (Figure 2a).
A further reversible and major quantitative marker of
oxidative damage to plasma protein are MetSO residues,
which are repaired by tissue MetSO reductase activity.22 The
MetSO residue content of plasma protein increased 57% in
the plasma protein of the sham-operated control, BNX, and
BUL rats within 3 h post-surgery, with respect to the baseline
control level. MetSO residue content then decreased in the
sham-operated control and BNX rats but increased further in
the BUL rats at 24 h (Figure 3a). MetSO free adduct is also
present in plasma arising from tissue proteolysis of oxidized
proteins, oxidation of methionine, and absorption from
ingested and digested proteins in food.20,22 The plasma
concentration of MetSO free adduct increased threefold from
baseline levels in the sham-operated control, BNX, and BUL
rats within 3 h of the post-surgery period. It decreased
rapidly to control values by 12 h in the sham-operated
controls and thereafter remained at this baseline level for
72 h. In contrast, plasma MetSO free adduct concentration of
the BNX and BUL rats continued to increase, reaching a
maximum of fourfold rise at 24 h and decreased to baseline
levels by 72 h (Figure 3b).
Dityrosine residue content of plasma protein is a
quantitatively minor and irreversible marker of oxidative
damage.22 It was not changed significantly in the sham-
operated control, BNX, and BUL rats (Figure 3c). In marked
contrast to the dityrosine residue content of plasma protein,
the plasma concentration of dityrosine free adduct increased
markedly and progressively in all operated groups but most
markedly in the BNX and BUL rats. By 72 h, plasma
dityrosine free adduct concentrations had increased from
baseline approximately 5-fold in the sham-operated control
rats, 150-fold in the BNX rats, and 60-fold in the BUL rats
(Figure 3d).
3-NT is a marker of protein nitration found at low levels
in plasma proteins.18 The 3-NT residue content of plasma
protein was increased fourfold from baseline in the sham-
operated control, BNX, and BUL rats after 3 h (Po0.001).
Thereafter, the 3-NT residue content decreased to baseline
values in the sham-operated control at 72 h post-surgery but
Table 1 | Body weight and blood chemistry of the control and
acute renal failure rats
Postoperation
time (h) Control (n=4)a BNX (n=4) BUL (n=4)
Body weight (g)
0 21675 ND ND
3 21373 20574 21375
12 21173 20873 21878
24 21575 22573 21375
72 21579 21474 22070
Plasma glucose (mM)
0 22.473.6 ND ND
3 19.271.1 16.872.1 21.572.0
12 13.970.2 7.770.7**,z 13.371.1++,z
24 11.770.5w 6.170.3**,z 8.271.1*,z
72 11.571.1z 6.371.1*,z 7.270.3 z
Urea (mM)
0 6.870.4 ND ND
3 8.270.8 11.571.5 15.470.6**
12 4.670.3z 30.271.5**,z 34.273.2**
24 4.470.2z 40.871.1**,z 46.872.7**,w
72 5.370.8w 96.771.2**,z 104.5717.3**,z
Creatinine (mM)
0 3274 ND ND
3 4374 10577** 8975**
12 5271 288715**,z 264712**,z
24 5773 43476**,z 362765**,z
72 4474 875769**,z 835721**,z
b2-Microglobulin (mg/ml)
0 ND ND ND
3 1.2970.07 3.9970.75* 2.4970.18
12 1.0170.16 5.9670.95** 2.1770.30++
24 1.1770.09 5.0270.80** 2.4770.23+
72 1.5970.25 ND 3.7470.45*,w
Potassium (mM)
0 4.570.2 ND ND
3 5.370.4 4.570.4 4.870.3
12 3.370.2 3.370.2z 4.170.6z
24 4.670.4 5.270.6z 5.070.4z
72 3.370.2 7.770.7**,z 9.070.5**,z
Albumin (mg/ml)
0 28.472.0 ND ND
3 34.671.8 34.371.4 34.674.0
12 28.171.7 30.272.3 28.272.8
24 25.771.5w 22.473.4z 30.471.1
72 33.073.6 20.071.0z 45.672.9*,+,w
BNX, bilateral nephrectomized; BUL, bilateral ureteral-ligated; ND, not determined.
aThe control group had n=4 except for t=0 baseline values for which n=5.
Significance: * and **, Po0.05 and Po0.01 with respect to control; + and ++,
Po0.05 and Po0.01 with respect to BNX, at the times indicated; and w and z, Po0.05
and Po0.01 with respect to the 3 h time point.
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remained increased in BNX and BUL rats—particularly in
the latter (Figure 3e). The plasma concentration of 3-NT free
adduct increased markedly and progressively in the BNX and
BUL rats but not in the sham-operated controls. The
maximum plasma concentrations of 3-NT free adduct in
BNX and BUL rats were achieved after 24 h—17- and 11-fold
increases, respectively (Figure 3f). These high levels of 3-NT
free adduct were maintained until 72 h post-surgery.
Markers of protein glycation in plasma
Important physiological glycating agents are glucose, glyoxal,
MG, and 3-DG. In rats without surgery, the postprandial
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concentration of plasma glucose averaged 22.477.3 mM.
Three hours post-surgery, glycemia was still markedly
increased in all study groups. Thereafter, plasma glucose
concentration returned to normal levels at 12 h in the BNX
rats, declining even further thereafter. In the BUL rats, it
declined slowly to baseline levels at 24 h and thereafter,
whereas in the sham-operated controls, plasma glucose
concentrations remained increased twofold from 12 to 72 h
post-surgery (Table 1). The rats had free access to food before
operation; thus, all values of plasma glucose concentration
can be considered postprandial. The lower blood glucose
levels in the BNX and BUL rats, compared to the sham-
operated controls, may reflect the loss and decreased renal
gluconeogenesis.23
The plasma concentration of glyoxal increased progres-
sively in the BNX and BUL rats but not in the sham-operated
controls in the post-surgery period. After 72 h, the plasma
concentration of glyoxal was increased fourfold in the BNX
and fivefold in the BUL rats with respect to baseline and the
sham-operated controls (Figure 2b). Plasma MG concentra-
tion showed a similar trend but was increased to a maximum
value at 24 h in the sham-operated controls. After 72 h post-
surgery, the plasma concentration of MG was increased
2-fold in the sham-operated controls, 6-fold in the BNX rats,
and 16-fold in the BUL rats, with respect to baseline (Figure
2c). In contrast, the concentration of 3-DG in plasma was
increased 4- to 6-fold after 3 h in all study groups, with
respect to the baseline value, and decreased to levels 2- to
3-fold higher than baseline after 72 h (Figure 2d).
The early stage adduct of glucose glycation, FL residues, is
a major quantitative glycation adduct of plasma protein.20
The FL residue content of plasma protein of the sham-
operated controls was not significantly different from the
baseline level, whereas it decreased progressively in BNX and
BUL rats to 41 and 50%, respectively, of the sham-operated
control value (Figure 4a). FL free adduct is a major glycation
free adduct of control rat plasma. The plasma concentration
of FL free adduct of all study groups did not differ from the
baseline level (Figure 4b).
CML residues are AGE formed by the oxidation degrada-
tion of FL residues and reaction of lysine residues with
glyoxal.14 The CML residue content of plasma protein of the
sham-operated control, BNX, and BUL rats was increased
approximately twofold at 3 h, with respect to baseline control
levels, and changed little thereafter in the 72 h post-surgery
period (Figure 4c). In marked contrast, the plasma
concentration of CML free adduct increased markedly in
the BNX and BUL rats but only modestly in the sham-
operated control rats. After 72 h, the CML free adduct
concentration was increased 2-fold in the sham-operated
controls, 23-fold in the BNX, and 9-fold in the BUL rats, with
respect to the baseline level (Figure 4d).
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CEL residues are AGE residues similar to CML except
formed by the reaction of lysine residues with MG.14 The
CEL residue content of plasma protein of the sham-operated
control, BNX, and BUL rats was increased approximately
twofold from the baseline level at 3 h and decreased slowly
over 72 h (Figure 4e). Similar to CML free adduct, the plasma
concentration of CEL free adduct increased markedly in the
BNX and BUL rats but was generally unchanged in the sham-
operated control rats. After 72 h, CEL free adduct concentra-
tion was increased 12-fold in the BNX and 7-fold in the BUL
rats (Figure 4f).
Arginine-derived hydroimidazolone residues are quantita-
tively important AGEs of plasma protein.14 The G-H1 residue
content of plasma protein of the sham-operated control,
BNX, and BUL rats was increased approximately 5- to 7-fold
at 3 h and decreased progressively over 72 h, with respect to
baseline levels (Figure 5a). The plasma concentration of
G-H1 free adduct increased markedly in the BNX and BUL
rats. After 72 h, G-H1 free adduct concentration was
increased 2-fold in the sham-operated controls, 14-fold in
the BNX rats, and 9-fold in the BUL rats, with respect to
baseline control levels (Figure 5b).
The MG-H1 residue content of plasma protein of the
sham-operated control, BNX, and BUL rats was increased
approximately 2- to 3-fold at 3 h post-surgery and decreased
progressively over 72 h, with respect to baseline levels (Figure
5c). The plasma concentration of MG-H1 free adduct
increased markedly in the BNX rats but not in the BUL
and sham-operated control rats. After 72 h, MG-H1 free
adduct concentration was increased eightfold in the BNX rats
(Figure 5d).
The 3DG-H residue content of plasma protein of the
sham-operated control, BNX, and BUL rats was increased
approximately 4-fold at 3 h post-surgery, with respect to
baseline levels, and decreased progressively thereafter (Figure
5e). The plasma concentration of 3DG-H free adduct
increased markedly in the BNX rats and modestly in the
BUL rats. After 72 h, 3DG-H free adduct concentration was
increased 13-fold in the BNX and 3-fold in the BUL rats
(Figure 5f).
An important effect of AGEs on protein structure and
function is the formation of non-sulfhydryl crosslinks.
Pentosidine residues are a widely studied fluorescent AGE
crosslink of plasma protein.14 The pentosidine content of
plasma protein of the sham-operated control, BNX, and BUL
rats was increased approximately fourfold at 3 h post-surgery,
with respect to baseline level, and decreased progressively
thereafter (Figure 6a). In contrast, the plasma concentration
of pentosidine free adduct increased markedly in BNX rats
and modestly in BUL rats. After 72 h, its plasma concentra-
tion was increased fivefold in the BNX and twofold in the
BUL rats (Figure 6b).
A further AGE crosslink is the lysine–lysine, MG-derived
crosslink MOLD. MOLD residue content of plasma protein
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adduct, (c) MG-H1 residues, (d) MG-H1 free adduct, (e) 3DG-H residues, and (f) 3DG-H free adduct. Key: hollow bars, sham-operated controls;
solid bars, BNX; and hatched bars, BUL. Data are mean7s.e.m. (n¼ 4). Significance: symbol key as in Figure 2. The baseline concentrations
of analytes were as follows: G-H1 residues 0.07170.016 mmol/mol lys; G-H1 free adduct 7879 nM; MG-H1 residues 0.45070.027 mmol/mol lys;
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of the sham-operated control, BNX, and BUL rats was
increased approximately twofold from baseline levels at 3 h
post-surgery and decreased slowly over 72 h (Figure 6c). The
plasma concentration of MOLD free adduct, however,
increased markedly in the BNX and BUL rats and only
modestly from baseline levels in the sham-operated control
rats. After 72 h, MOLD free adduct concentration was
increased 2-fold in sham-operated controls, 14-fold in the
BNX rats, and 6-fold in the BUL rats (Figure 6d).
DISCUSSION
This study has revealed significant increases in plasma
concentrations of protein glycation, oxidation, and nitration
free adducts in experimental ARF without increases in related
adduct residues in plasma protein.
BNX and similar models of acute and severe renal
insufficiency are associated with oxidative and nitrosative
stress.7 The major effects observed in BNX rats were the
increased plasma concentration and delayed repair of MetSO
free adduct, and sustained marked increased concentrations
of protein oxidation, nitration, and AGE free adducts:
dityrosine 150-fold, 3-NT 17-fold, CML 23-fold, CEL 12-
fold, MOLD 14-fold, G-H1 14-fold, MG-H1 8-fold, 3DG-H
13-fold, and pentosidine 5-fold at 72 h post-surgery. FL free
adduct did not accumulate in BNX rats most likely as it is
metabolized by fructosamine 3-phosphokinase extrarenally.24
These adducts are normally excreted in urine16,25 and are
increased in renal failure.1 Loss of renal clearance and urinary
excretion in BNX rats led to plasma accumulation. For
glycation and oxidation free adducts with low rates of
metabolism (CEL, MG-H1, MOLD, pentosidine, and dityro-
sine), the rates of accumulation in the initial post-surgery
period (3–12 h) were approximately equivalent to the rates of
urinary excretion of normal control rats. For example, the
maximum rate of accumulation of pentosidine free adduct in
BNX rats (from 3 to 12 h post-surgery) was equivalent
to 9–31 pmol/h—assuming a volume of distribution similar
to dipeptides (80–270 ml/kg body weight).26 This is similar to
the rate of urinary excretion of pentosidine in normal control
rats: 1272 pmol/h (n¼ 13). The accumulation of glycation
and oxidation free adducts in BNX rats was, therefore, similar
to that expected for total loss of renal clearance. The
accumulation of CML free adduct exceeded the normal
urinary excretion rate, which may reflect increased oxidative
degradation of FL to CML in BNX rats. The attenuation of
the rate of increase in plasma concentrations from 24 to 72 h
post-surgery may be due to increased protein binding, tissue
permeability (reverse flow from plasma into tissues), and
metabolism of free adducts at high concentrations. These
processes influence the maximum free adduct concentration
achieved at 72 h post-surgery.
BUL is a model of ureteral obstruction and is character-
ized by decreased renal blood flow,27 decline in glomerular
filtration rate,28 and oxidative stress.29 The BUL rats showed
prolonged increased MetSO and 3-NT residue content of
plasma protein and increased plasma concentration, and
delayed repair of MetSO free adduct. The most marked effect
was, however, the increase in the plasma concentrations of
oxidation, nitration, and AGE free adducts: dityrosine 60-
fold, 3-NT 11-fold, CML 9-fold, CEL 7-fold, MOLD 6-fold,
G-H1 9-fold, 3DG-H 3-fold, and pentosidine 2-fold at 72 h
post-surgery. These increases were, however, 25–77% lower
than in BNX rats and for MG-H1 free adduct there was no
increase at all in BUL rats. Although the normal excretion
route of these free adducts was blocked, BUL rats retained the
ability to clear them from the plasma. In the BUL rats, the
kidneys still have a residual glomerular filtration rate,
allowing filtration of oxidation, nitration, and AGE free
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adducts with their subsequent removal in the tubular system.
This provides in vivo evidence of intrarenal removal of
protein glycation, oxidation, and nitration adduct without
urinary excretion.
In contrast to this, the increases in the dicarbonyl
glycating agents, glyoxal and MG, were comparable in BNX
and BUL rats or greater in BUL than BNX rats—particularly
at 72 h post-surgery. Important sources of plasma 3-DG
formation are degradation of glucose-derived Schiff ’s base
adduct and FL residues,30 whereas glyoxal and MG are
formed mainly by lipid peroxidation and fragmentation of
triosephosphates, respectively.31 Although glyoxal and MG
are excreted in urine,32,33 495% of glyoxal and MG is
metabolized by the endogenous glyoxalase system.34 The
concentration of 3-DG was increased 3 h post-surgery and
decreased thereafter. The progressive increases of MG and
glyoxal in the post-surgery period may be due to developing
metabolic stress in tissues; accumulation of renal toxins may
enhance the formation of these dicarbonyls and/or inhibit
their metabolism.
There were some surprising similarities in sham-operated
control, BNX, and BUL rats. The oxidation, nitration, and
glycation adduct residue contents of plasma protein of the
three study groups were similar except for decreased FL
residue content in BNX and BUL rats and increase dityrosine,
3-NT, and CML residues in BUL rats. BUL rats exhibited
increased oxidative and nitrosative damage to plasma
protein; a further contribution to this may be oxidative
degradation of FL residues with concomitant formation of
CML residues. Protein oxidation, nitration, and oxidative
degradation of FL to CML are relatively rapid reactions under
physiological conditions,30,35,36 consistent with changes in
related protein adduct residues over the short time period
studied. This suggests that there is limited direct elimination
of oxidized, nitrated, and glycated proteins by the kidney.
Elimination of protein oxidation, nitration, and AGE adducts
occurs by clearance and excretion of corresponding free
adducts after proteolysis, as suggested previously.1,37
A further feature common to the three study groups was a
trend of the AGE residue content of plasma protein to
increase from baseline 3 h after surgery and thereafter
decrease over the period of study. The initial increase may
reflect decreased albumin synthesis immediately post-
surgery38 and the later decrease may reflect increased
transcapillary flow of plasma proteins post-surgery associated
with the inflammatory process,39 leading to plasma protein
replacement by restored de novo protein synthesis. All three
study groups showed a burst of oxidative stress—as indicated
by increased MetSO and 3-NT residues and MetSO free
adduct at 3 h, a decrease in plasma thiols at 12 h, and
increased dityrosine free adduct from 3 to 72 h post-surgery
(although the latter was markedly lower for sham-operated
control than BNX and BUL rats). This may also be linked to
the post-surgery inflammatory process. Protein thiol and
MetSO residue content and MetSO free adduct concentration
recovered when reparative mechanisms took effect.
In summary, we found for the first time important
increases in glyoxal, MG and dityrosine, 3-nitrotyrosine, and
AGE free adducts in rat models of acute renal failure.
MATERIALS AND METHODS
Animals and treatment
Fifty-three male Wistar rats (180–220 g, Velas, Prague, Czech
Republic) were used. Rats were housed 4–5 animals per cage, under
conditions of controlled humidity, room temperature, and a 12 h
light/dark cycle. They had free access to drinking water and rat chow.
During quarantine (10 days), the rats were fed a standard rat food in
the form of pellets (SP1, Top Dovo, Czech Republic). Five days before
operation and during the trial, the rats were fed a low-potassium diet
(Altromin, Lage, Germany). Acute renal failure (ARF) was induced
either by BNX of the decapsulated kidneys (n¼ 16) or by BUL
(n¼ 16), under anesthesia (i.p., ketamine, 75 mg/kg, and xylazine,
10 mg/kg, Spofa, Hlohovec, Slovakia). Sixteen sham-operated rats
served as controls. Four rats from each group were sacrificed 3, 12, 24,
and 72 h after the induction of ARF. Moreover, five nonoperated,
healthy rats were sacrificed to obtain basal values.
Research design and method
Before the rats were sacrificed, body weight was recorded and blood
samples for standard biochemistry (plasma glucose, urea, creatinine,
albumin, and potassium concentration; Vitros 250 analyzer, Johnson
& Johnson, Rochester, NY, USA) were collected from the abdominal
aorta under anesthesia. If not analyzed immediately, the plasma was
stored at 701C, then dispatched on dry ice to the collaborating
laboratory (Colchester, UK) and there stored at 801C until analysis.
b2-Microglobulin concentration was determined by enzyme-linked
immunosorbent assay method (Alpha Diagnostic International, San
Antonio, TX, USA). The investigation was conducted according to the
guidelines for studies using laboratory animals (86/609/EEC), after
the approval of the protocol by the Institutional Ethics Committee for
Experimental Animals (Bratislava, Slovakia).
Other biochemical markers
Plasma glyoxal, MG, and 3-DG, and protein glycation, oxidation,
and nitration adducts were assayed by liquid chromatography with
tandem mass spectrometric detection.1,40 Protein glycation, oxida-
tion, and nitration free adducts were determined by assay of analytes
in ultrafiltrate (12 kDa filter cutoff, 50 ml aliquot) of plasma.
Glycation adduct residues of plasma protein were determined in
exhaustive enzymatic digests (50 mg protein equivalent).1 Plasma
protein thiols were determined by derivatization with Ellman’s
reagent.41
Statistical analyses
Statistical analysis was performed using the Statgraphics version 5
and SPSS version 8 statistical program. Two-way analysis of variance
was used to determine the impact of mode of operation and that of
time elapsed after operation. If Po0.05 was obtained, the
Kruskal–Wallis test or one-way analysis of variance was used to
compare the means between the groups, and post hoc Scheffe’s,
Dunnett’s or Mann–Whitney test was performed, as appropriate.
Results are given as mean7s.e.m.
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